Agfa-gevaert Nv · EURONEXT:AGFB
Agfa-gevaert Nv — Q3 2012 Earnings Presentation
18 slides from Agfa-gevaert Nv's earnings presentation, Nov 14, 2012
Slide 1: Q3 2012 Results
Q3 2012 Results November 14, 2012
Slide 2: Profit & Loss: Key Figures (in million Euro)
Profit & Loss: Key Figures (in million Euro) Q3'11 Q3'12 ∆% 9M'11 9M'12 ∆% (excl. X-rate) (excl. X-rate) Sales 719 766 6.5% (0.5%) 2,218 2,279 2.8% (-1.3%) Gross Profit* 181 209 15.5% 628 643 2.4% as a % of sales 25.2% 27.3% 28.3% 28.2% SG&A* -133 -140 5.3% -425 -431 1.4% SG&A as % of sales 18.5% 18
Slide 3: Net Financial Debt (in million Euro)
Net Financial Debt (in million Euro) 661 569 500 445 434 391 398 313 339 306 267 291 295 161 189 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q210 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 3
Slide 4: Working Capital: Key Figures (in million Euro/days)
Working Capital: Key Figures (in million Euro/days) 800 Inventories 800 Trade Receivables* 800 Trade Payables 700 717 719 711 700 700 688 688 691 600 627 639 600 600 591 585 583 577 543 539 500 514 500 521 532 527 500 483 482 496 487 482 469 473 471 467 476 438 452 400 400 400 300 300 300 119 123123
Slide 5: Main Group Drivers behind Key Figures
Main Group Drivers behind Key Figures Q3 2012 • Industrial inkjet and healthcare IT continued to perform well • Thanks to the Group’s efforts to improve operational efficiency, gross margin continued to recover year-on-year. • Recurring EBIT at 29 million Euro • Net debt at 295 million Euro 5
Slide 6: Profit & Loss: Key Figures (in million Euro)
Profit & Loss: Key Figures (in million Euro) Q3 '11 Q3 '12 ∆% 9M'11 9M'12 ∆% Recurring EBIT* 10 29 190.0% 86 82 -4.7% Restructuring and non-recurring -19 -2 -38 -23 Operating result -9 27 48 59 Non-operating result -22 -25 -65 -82 Profit before taxes -31 2 -17 -23 Taxes -6 -6 -11 -12 Net result -37
Slide 7: Graphics
Graphics AGFA &
Slide 8: Graphics: Key Figures (in million Euro)
Graphics: Key Figures (in million Euro) Q3'11 Q3'12 ∆% 9M'11 9M'12 ∆% (excl. curr.) (excl. curr. ) Sales 387 417 7.8% (1.4%) 1,178 1,231 4.5% (-0.2%) Gross Profit* 90 100 11.1% 305 308 1.0% as a % of sales 23.3% 24.0% 25.9% 25.0% SG&A* -75 -76 1.3% -235 -237 0.9% as % of sales 19.4% 18.2% 19.9% 19.3
Slide 9: Graphics: Main Drivers
Graphics: Main Drivers Q3 2012 • Industrial Inkjet posted double-digit growth. • In prepress, volume increases were counterbalanced by competitive pressure. • The CtP business suffered from the weakness of the economy in Europe, but performed well in the rest of the world. • Sales in CtF were up ver
Slide 10: Graphics: YTD Sales per Business Segment
Graphics: YTD Sales per Business Segment 9m 2012 100% = 1,231 million Euro Inkjet, Software, Service 17% Analog Prepress 19% Digital Prepress 64% 10
Slide 11: HealthCare
HealthCare AGFA &
Slide 12: HealthCare: Key Figures (in million Euro)
HealthCare: Key Figures (in million Euro) Q3'11 Q3'12 ∆% 9M'11 9M'12 ∆% (excl. curr.) (excl. curr. ) Sales 267 297 11.2% (5.1%) 844 875 3.7% (0.0%) Gross Profit* 86 104 20.9% 294 313 6.5% as a % of sales 32.2% 35.0% 34.8% 35.8% SG&A* -54 -58 6.9% -173 -175 1.1% as % of sales 20.2% 19.5% 20.5% 20.0%
Slide 13: HealthCare: Main Drivers
HealthCare: Main Drivers Q3 2012 • The digital radiography business performed well, adding to the continued growth of healthcare IT. • Compared to the very weak Q3 2011, film volumes also increased. • Continuing the trend of the past quarters, gross profit improved versus last year, reflecting the f
Slide 14: HealthCare: YTD Sales per Business Segment
HealthCare: YTD Sales per Business Segment 9m 2012 100% = 875 million Euro Hardcopy 30% Classic Radiology 12% CR/Modalities 19% Imaging IT* HIS/CIS 27% 12% HealthCare IT = 39% * Includes Radiology and Cardiology IT 14
Slide 15: Specialty Products
Specialty Products AGFA &
Slide 16: Specialty Products: Key Figures (in million Euro)
Specialty Products: Key Figures (in million Euro) Q3'11 Q3'12 ∆% 9M'11 9M'12 ∆% (excl. curr.) (excl. curr. ) Sales 65 52 -20.0% (-23.1%) 196 173 -11.7% (-13.5%) Gross Profit* 6 5 -16.7% 29 22 -24.1% as a % of sales 9.2% 9.6% 14.8% 12.7% SG&A* -5 -5 0.0% -17 -18 5.8% as % of sales 7.7% 9.6% 8.7% 10.4
Slide 17: Specialty Products: Main Drivers
Specialty Products: Main Drivers Q3 2012 • The various businesses evolved in line with previous quarters. • Recurring EBIT at minus 2.1 million Euro. 17
Slide 18: Q&A
Q&A AGFA &